600873 梅花生物
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)13.81822.98536.43224.31610.872
总资产报酬率 ROA (%)8.54713.35219.38112.0195.127
投入资产回报率 ROIC (%)9.63415.31822.41313.9476.147

边际利润分析
销售毛利率 (%)18.90419.68125.13319.40614.671
营业利润率 (%)12.17113.73718.47112.7036.956
息税前利润/营业总收入 (%)12.15313.29118.74413.2717.738
净利润/营业总收入 (%)10.68111.45915.77210.5265.897

收益指标分析
经营活动净收益/利润总额(%)86.75896.74696.00891.57696.838
价值变动净收益/利润总额(%)1.260-0.8191.1079.915-3.946
营业外收支净额/利润总额(%)2.916-2.424-0.143-1.596-0.656

偿债能力分析
流动比率 (X)1.1901.4561.4861.3541.062
速动比率 (X)0.9331.0090.8760.8190.637
资产负债率 (%)37.46338.84044.81349.12850.948
带息债务/全部投入资本 (%)27.75028.28733.07638.45440.801
股东权益/带息债务 (%)252.294245.454193.365152.614136.928
股东权益/负债合计 (%)166.931157.469123.151103.55093.895
利息保障倍数 (X)-31.667-110.38262.43317.2969.360

营运能力分析
应收账款周转天数 (天)9.3916.3674.0044.1816.200
存货周转天数 (天)42.70756.43760.76350.50253.890